Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Hua-Zhen Xu
Doxorubicin-Polyglycerol-Nanodiamond Conjugate Is a Cytostatic Agent That Evades Chemoresistance and Reverses Cancer-Induced Immunosuppression in Triple-Negative Breast Cancer
Journal of Nanobiotechnology
Applied Microbiology
Molecular Medicine
Nanoscience
Pharmaceutical Science
Medicine
Biotechnology
Bioengineering
Biomedical Engineering
Nanotechnology
Related publications
Cholecalciferol-Peg Conjugate Based Nanomicelles of Doxorubicin for Treatment of Triple-Negative Breast Cancer
AAPS PharmSciTech
Evolution
Ecology
Systematics
Crop Science
Aquatic Science
Behavior
Pharmaceutical Science
Medicine
Agronomy
Drug Discovery
Targeting Stromal Remodeling and Cancer Stem Cell Plasticity Overcomes Chemoresistance in Triple Negative Breast Cancer
Nature Communications
Astronomy
Genetics
Molecular Biology
Biochemistry
Chemistry
Physics
Triple-Negative Breast Cancer
Triple Negative Breast Cancer: Breast Cancer Research in Evolution
Breast Disease
Medicine
Cancer Research
Oncology
Brachyury, a Vaccine Target, Is Overexpressed in Triple-Negative Breast Cancer
Endocrine-Related Cancer
Cancer Research
Endocrinology
Oncology
Metabolism
Diabetes
A Review of Triple-Negative Breast Cancer
Cancer Control
Medicine
Oncology
Hematology
Triple Negative Breast Cancer: Heterogenous Disease
REVIEWS IN ONCOLOGY
FZD7 in Triple Negative Breast Cancer Cells
T‑cadherin Is Associated With Prognosis in Triple‑negative Breast Cancer
Oncology Letters
Cancer Research
Oncology